Pulmonary vasoreactivity predicts long-term outcome in patients with Eisenmenger syndrome receiving bosentan therapy
Michele D’Alto(Ospedale Monaldi), Raffaele Calabrò(University of Campania "Luigi Vanvitelli"), Emanuele Romeo(University of Campania "Luigi Vanvitelli"), Gianpiero Gaio(University of Campania "Luigi Vanvitelli"), Berardo Sarubbi(Parthenope University of Naples), Maria Giovanna Russo(University of Campania "Luigi Vanvitelli"), Paola Argiento(University of Campania "Luigi Vanvitelli"), Robert Naeije(Erasmus Hospital), Christian Mélot(Erasmus Hospital)
Cited by 37
Related Papers
Inhaled Iloprost for Severe Pulmonary Hypertension
|New England Journal of Medicine|2002|1.8k
A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study
|Intensive Care Medicine|2009|906
EuReCa ONE27 Nations, ONE Europe, ONE Registry
|Resuscitation|2016|836